Mycobacterium Citations List: July 2024

Literature Citations

1. GC-MS Based Metabolomic Profiling of Aporosa cardiosperma (Gaertn.) Merr. Leaf Extracts and Evaluating Its Therapeutic Potential. Abdul, U., D.B. Manikandan, M. Arumugam, S.Y. Alomar, S. Manoharadas, and T. Ramasamy. Scientific Reports, 2024. 14(1): p. 16010. PMID[38992053]. PMCID[PMC11239809].
[PubMed]. TB_07_2024.

2. Inhibition of DXR in the MEP Pathway with Lipophilic N-alkoxyaryl FR900098 Analogs. Bague, D., R. Wang, D. Hodge, M.O. Mikati, J.S. Roma, H.I. Boshoff, A.L. Dailey, M. Girma, R.D. Couch, A.R. Odom John, and C.S. Dowd. RSC Medicinal Chemistry, 2024. 15(7): p. 2422-2439. PMID[39026652]. PMCID[PMC11253873].
[PubMed]. TB_07_2024.

3. Robust Anti-tubercular Profile of Solanum virginianum Extract in Enhancing Isoniazid Bioavailability and Curtailing Stress Tolerance in Mycobacterium smegmatis. Balkrishna, A., M. Joshi, M. Kabdwal, M. Tomer, S. Lochab, and A. Varshney. Frontiers in Microbiology, 2024. 15: p. 1429027. PMID[39081888]. PMCID[PMC11286421].
[PubMed]. TB_07_2024.

4. Design, Synthesis and Computational Studies of New Azaheterocyclic coumarin Derivatives as Anti-mycobacterium tuberculosis Agents Targeting Enoyl Acyl Carrier Protein Reductase (InhA). Batran, R.Z., A. Sabt, J. Dziadek, and A.F. Kassem. RSC Advances, 2024. 14(30): p. 21763-21777. PMID[38984262]. PMCID[PMC11232110].
[PubMed]. TB_07_2024.

5. Design, Synthesis and Biological Evaluation of (Z)-1-(Benzo[D]Thiazol-2-yl)-2-(3-substituted thiazolidine-4-one) Hydrazine Dpre1 Inhibitors as Antimycobacterial Agents. Bonde, C.G., R.P. Bhole, A. Asrodkar, R. Chikhale, and S.S. Gurav. Pharmaceutical Chemistry Journal, 2024. 58: p. 454-431. ISI[001267721600002].
[WOS]. TB_07_2024.

6. Omadacycline Drug Susceptibility Testing for Non-tuberculous mycobacteria Using Oxyrase to Overcome Challenges with Drug Degradation. Boorgula, G.D., T. Gumbo, S. Singh, P.J. McShane, J.V. Philley, and S. Srivastava. Tuberculosis, 2024. 147: p. 102519. PMID[38754247].
[PubMed]. TB_07_2024.

7. Psoralea corylifolia L. and its Active Component Isobavachalcone Demonstrate Antibacterial Activity against Mycobacterium abscessus. Cao, D., Z. Zhang, X. Jiang, T. Wu, Y. Xiang, Z. Ji, J. Guo, X. Zhang, K. Xu, Z. Liu, and Y. Zhang. Journal of Ethnopharmacology, 2024. 329: p. 118142. PMID[38583730].
[PubMed]. TB_07_2024.

8. Synthesis and Antibacterial Action of 3',6'-disubstituted Spectinomycins. Dharuman, S., G.A. Phelps, C.M. Dunn, L.A. Wilt, P.A. Murphy, R.B. Lee, H.E. Snoke, P. Selchow, K. Haldimann, E.C. Böttger, S.N. Hobbie, P. Sander, and R.E. Lee. The Journal of Antibiotics, 2024. PMID[38890386].
[PubMed]. TB_07_2024.

9. Expanding the Chemical Space of Ester of Quinoxaline-7-carboxylate 1,4-di-N-oxide Derivatives as Potential Antitubercular Agents. González-González, A., O. Sanchez-Sánchez, B.J. Wan, S. Franzblau, I. Palos, J.C. Espinoza-Hicks, A. Moreno-Rodríguez, A.V. Martínez-Vázquez, E.E. Lara-Ramírez, E. Ortiz-Pérez, A.D. Paz-González, and G. Rivera. RSC Medicinal Chemistry, 2024. ISI[001270353400001].
[WOS]. TB_07_2024.

10. Imidazoquinoline Derivatives as Potential Inhibitors of InhA Enzyme and Mycobacterium tuberculosis. Hoffmann, P., J. Azéma-Despeyroux, F. Goncalves, A. Stamilla, N. Saffon-Merceron, F. Rodriguez, G. Degiacomi, M.R. Pasca, and C. Lherbet. Molecules, 2024. 29(13). PMID[38999028]. PMCID[PMC11243711].
[PubMed]. TB_07_2024.

11. Efficacies of Omadacycline + Amikacin + Imipenem and an All-oral Regimen Omadacycline + Clofazimine + Linezolid in a Mouse Model of M. abscessus Lung Disease. Ignatius, E.H., B. Rimal, C.M. Panthi, D.C. Belz, C.K. Lippincott, D.H. Deck, A.W. Serio, and G. Lamichhane. mSphere, 2024. 9(7): e0038124. PMID[38980071]. PMCID[PMC11288010].
[PubMed]. TB_07_2024.

12. New Coumarin Linked Thiazole Derivatives as Antimycobacterial Agents: Design, Synthesis, Enoyl Acyl Carrier Protein Reductase (InhA) Inhibition and Molecular Modeling. Kassem, A.F., A. Sabt, M. Korycka-Machala, M.A. Shaldam, M. Kawka, B. Dziadek, M. Kuzioła, J. Dziadek, and R.Z. Batran. Bioorganic Chemistry, 2024. 150: p. 107511. PMID[38870705].
[PubMed]. TB_07_2024.

13. Antimicrobial Susceptibility Analysis of Isepamicin Combination Treatments in Mycobacterium abscessus Species. Kato, Y., H. Ihara, S. Takei, A. Nakamura, Y. Fujimoto, T. Handoh, K. Kurokawa, Y. Arai, K. Shibayama, I. Sumiyoshi, Y. Ochi, J. Watanabe, K. Hoshi, S. Misawa, S. Togo, T. Naito, Y. Tabe, T. Miida, and K. Takahashi. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases , 2024. 36: p. 100464. PMID[39099802]. PMCID[PMC11295537].
[PubMed]. TB_07_2024.

14. An O-methylflavone from Artemisia afra Kills Non-replicating Hypoxic Mycobacterium tuberculosis. Kellogg, J.J., M.N. Alonso, R.T. Jordan, J. Xiao, J.H. Cafiero, T. Bush, X. Chen, M. Towler, P. Weathers, and S.S. Shell. Journal of Ethnopharmacology, 2024. 333: p. 118500. PMID[38944359]. PMCID[PMC11285045].
[PubMed]. TB_07_2024.

15. Design, Synthesis, and Anti-mycobacterial Evaluation of 1,8-naphthyridine-3-carbonitrile Analogues. Khetmalis, Y.M., S. Shobha, A. Nandikolla, A. Chandu, S. Murugesan, M.M.K. Kumar, and K.V.G. Chandra Sekhar. RSC Advances, 2024. 14(31): p. 22676-22689. PMID[39027042]. PMCID[PMC11255784].
[PubMed]. TB_07_2024.

16. Crystal Structure, DFT Calculation, Molecular Docking, In Vitro Biological Activity Evaluation and In Silico Drug-likeness Prediction of N-((1H-indol-3-yl)methyl)-4-(piperidin-1-yl)aniline. Liu, T., L. Luan, Z. Zhang, Z.Y. Li, C.J. Wu, and T.M. Sun. Journal of Molecular Structure, 2024. 1312: 138609. ISI[001245151500001].
[WOS]. TB_07_2024.

17. Exploring Rhodanine Linked Enamine-carbohydrazide Derivatives as Mycobacterial Carbonic Anhydrase Inhibitors: Design, Synthesis, Biological Evaluation, and Molecular Docking Studies. Maddipatla, S., B. Bakchi, R.R. Gadhave, A. Ammara, S. Sau, B. Rani, S. Nanduri, N.P. Kalia, C.T. Supuran, and V.M. Yaddanapudi. Archiv der Pharmazie, 2024. 357(7): e2400064. PMID[38498883].
[PubMed]. TB_07_2024.

18. Design, Synthesis and Molecular Docking Study of Novel Triazole-quinazolinone Hybrids as Antimalarial and Antitubercular Agents. Mhetre, U.V., N.B. Haval, G.M. Bondle, S.S. Rathod, P.B. Choudhari, J. Kumari, D. Sriram, and K.P. Haval. Bioorganic & Medicinal Chemistry Letters, 2024. 108: p. 129800. PMID[38763480].
[PubMed]. TB_07_2024.

19. Antimycobacterial and Anticancer Properties of Myrtus communis Leaf Extract. Mir, M.A., L.A. Memish, S.E. Elbehairi, N. Bashir, F.S. Masoud, A.A. Shati, M.Y. Alfaifi, A.M. Alamri, S.A. Alkahtani, and I. Ahmad. Pharmaceuticals, 2024. 17(7). PMID[39065723]. PMCID[PMC11279575].
[PubMed]. TB_07_2024.

20. Relative Contributions of the Novel Diarylquinoline TBAJ-876 and its Active Metabolite to the Bactericidal Activity in a Murine Model of Tuberculosis. Mudde, S.E., N.C. Ammerman, M.T. Ten Kate, N. Fotouhi, M.U. Lotlikar, H.I. Bax, and J.E.M. de Steenwinkel. The Journal of Infectious Diseases, 2024. PMID[38941358].
[PubMed]. TB_07_2024.

21. Targeting Tuberculosis: Novel Scaffolds for Inhibiting Cytochrome bd Oxidase. Seitz, C., S.H. Ahn, H. Wei, M. Kyte, G.M. Cook, K.L. Krause, and J.A. McCammon. Journal of Chemical Information and Modeling, 2024. 64(13): p. 5232-5241. PMID[38874541].
[PubMed]. TB_07_2024.

22. Crystal Structure and In Vitro Biological Studies of a Pt(II) Complex Based on Gallic Acid and Triphenylphosphine. Silva, R.T.C., P.P. Silva-Caldeira, F.M. Demarqui, C.D. Lopes, S. de Albuquerque, F.R. Pavan, E.C. Pereira-Maia, R. Diniz, A. de Oliveira, C.D. Rezende, Jr., and W. Guerra. Inorganica Chimica Acta, 2024. 569: 122124. ISI[001265901800001].
[WOS]. TB_07_2024.

23. Design, Synthesis, Computational Molecular Docking Studies of Novel Heterocyclics Bearing 1,2,4-triazole, 1,3,4-oxadiazole Conjugates as Potent Antibacterial and Antitubercular Agents. Sravanthi, B., G. Himavathi, A.R. Robert, P. Karunakar, K.S. Kiran, and S. Maddila. J Journal of Biomolecular Structure and Dynamics, 2024. 42(10): p. 5376-5389. PMID[37340639].
[PubMed]. TB_07_2024.

24. New Generation Fluoroquinolone Sitafloxacin Could Potentially Overcome the Majority Levofloxacin and Moxifloxacin Resistance in Multidrug-resistant Mycobacterium tuberculosis. Sun, Q., K. Cheng, X. Liao, W. Zhao, C. Wang, C. Wang, J. Yan, L. Dong, F. Wang, G. Jiang, H. Huang, Z. Guo, and G. Wang. Journal of Medical Microbiology, 2024. 73(7). PMID[39028256].
[PubMed]. TB_07_2024.

25. Apramycin Has High In Vitro Activity against Mycobacterium tuberculosis. Sun, Q., J. Yan, S. Long, Y. Shi, G. Jiang, H. Li, H. Huang, and G. Wang. Journal of Medical Microbiology, 2024. 73(7). PMID[38973691].
[PubMed]. TB_07_2024.

26. Identification of Kinase Inhibitors as Potential Host-directed Therapies for Intracellular Bacteria. van den Biggelaar, R., K.V. Walburg, S.J.F. van den Eeden, C.L.R. van Doorn, E. Meiler, A.S. de Ries, M.C. Fusco, A.H. Meijer, T.H.M. Ottenhoff, and A. Saris. Scientific Reports, 2024. 14(1): p. 17225. PMID[39060313]. PMCID[PMC11282061].
[PubMed]. TB_07_2024.

27. Identification of Potent Indolizine Derivatives against Mycobacterial tuberculosis: In Vitro Anti-tb Properties, In Silico Target Validation, Molecular Docking and Dynamics Studies. Venugopala, K.N., S. Chandrashekharappa, P.K. Deb, N.A. Al-Shar'i, M. Pillay, P. Tiwari, D. Chopra, P. Borah, R. Tamhaev, L. Mourey, C. Lherbet, B.E. Aldhubiab, C. Tratrat, M. Attimarad, A.B. Nair, N. Sreeharsha, R.P. Mailavaram, R. Venugopala, V. Mohanlall, and M.A. Morsy. International Journal of Biological Macromolecules, 2024. 274 (Pt 2): p. 133285. PMID[38925196].
[PubMed]. TB_07_2024.

28. Molecular Periphery Design Allows Control of the New Nitrofurans Antimicrobial Selectivity. Vinogradova, L., A. Lukin, K. Komarova, M. Zhuravlev, A. Fadeev, M. Chudinov, E. Rogacheva, L. Kraeva, M. Gureev, Y. Porozov, M. Dogonadze, and T. Vinogradova. Molecules, 2024. 29(14). PMID[39064943]. PMCID[PMC11279955].
[PubMed]. TB_07_2024.

29. In Vitro Effects of the New Oral β-lactamase Inhibitor Xeruborbactam in Combination with Oral β -lactams against Clinical Mycobacterium abscessus Isolates. Yamatani, I., A. Aono, K. Fujiwara, T. Asami, K. Kamada, Y. Morishige, Y. Igarashi, K. Chikamatsu, Y. Murase, H. Yamada, A. Takaki, K. Komiya, and S. Mitarai. Microbiology Spectrum, 2024. 12(7): e0008424. PMID[38842354]. PMCID[PMC11218443].
[PubMed]. TB_07_2024.

Patent Citations

This month, no relevant Mycobacterium patents were identified.